Oncology/Haematology Flashcards
Most common human platelet antigen in FNAIT
Anti HPA 1a 85%
5b second most common in caucasian population
HPA 4 most common in Asian population
ALL
Standard risk
High risk
Standard:
1-9yo
WCC <50
Without 9:22 or 4:11
High risk:
>10
WCC > 50
ALL 12:21
25% of children
TEL-AML1
Excellent prognosis
What do the southern, Norther and western blot identify?
Southern: DNA
Northern: RNA
Western: protein
Bernard-Soulier syndrome
BSS is one of a group of hereditary platelet disorders characterised by thrombocytopenia, giant platelets, and a tendency toward bleeding. The bleeding time and platelet aggregation studies would be needed to point towards this.
Glanzmann thrombasthenia.
Glanzmann thrombasthenia (GT) is a genetic platelet disorderin which the platelets have qualitative or quantitative deficiencies of the fibrinogen receptor αIIbβ3.
Neonatal alloimmune thrombocytopenic pupura.
NAIT is caused when the mother’s and baby’s platelets become incompatible, a condition known as platelet alloimmunisation.Platelet alloimmunisation happens when a mother’s body forms antibodies in reaction to antigens that are different from her own. The outcome is low platelets.In about one fourth of cases, the baby can experience spontaneous bleeding into the brain; in about one third of these cases, this leads to foetal death.
Chemotherapy agents causing secondary malignancy
Cyclophosphamide
Etoposide (AML)
Blood film showing teardrop cells and target cells microcytic anaemia
Thalassemia trait
Beta thalassemia minor
Normal red cell distribution width
Cold AIHA
% of AIHA
Associations
Antibodies
Blood film
10%
EBV/mycoplasma
IgM
Red cell clumping
Warm AIHA
Clinical signs
Blood film
Jaundice, splenomegaly
Spherocytes (EMA neg)
Clinical signs of acute splenic sequestration
Engorgement of the spleen (rapid increase in size), hypovolemia, decreased Hb (can have retics)
Elevation of HbA2 level
Confirms diagnosis of beta thalassemia trait (4-6%)
Half Life of vitamin K dependent proteins
II 60HRS VII 4-6hrs IX 24hrs X 24-48 hrs Protein C 8 hours Protein S 30 hours
vWD
- frequency
- genetics
- cause
- Ix
Common 1 in 100 (1 in 1000 symptomatic)
Autosomal dominant
Absent, defective or ineffective vWF. vWF acts as an adhesive bridge between platelets and subendothelial structures
Prolonged APTT, normal PT, low Factor VIII